Adaptimmune Therapeutics shares owned by Syncona Portfolio
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Syncona Portfolio
from 13F filings
Historical chart of Syncona Portfolio investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Syncona Portfolio consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Syncona Portfolio
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.1M | 1.4M | 0.79 |
| 2023-09-30 | $1.1M | 1.4M | 0.78 |
| 2023-06-30 | $1.3M | 1.4M | 0.93 |
| 2023-03-31 | $1.5B | 1.4M | 1090.00 |
| 2022-12-31 | $2.0B | 1.4M | 1460.00 |
| 2022-09-30 | $1.5M | 1.4M | 1.08 |
| 2022-06-30 | $2.3M | 1.4M | 1.70 |
| 2022-03-31 | $5.2M | 1.4M | 3.75 |
| 2021-12-31 | $5.2M | 1.4M | 3.75 |
More positions owned by Syncona Portfolio
View all positions for Syncona Portfolio